Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Rashmi Kumari

HISTORICAL FACTS: How is johnson johnson s stock performance compared to other pharmaceutical stocks | History Defined

New Jersey-based Johnson & Johnson (JNJ) is a global healthcare powerhouse valued at $355.71 billion by market cap. It researches, develops, manufactures, and sells a wide range of healthcare products worldwide. Competing fiercely with other healthcare giants, one of JNJ's main rivals is Pfizer Inc. (PFE), which also has a strong presence in pharmaceuticals and consumer health.

Companies worth $200 billion or more are generally described as “mega-cap stocks,” and JNJ fits right into that category. Its market cap exceeds this threshold, reflecting its substantial size, stability, and influence in the healthcare sector. The healthcare giant has pivoted toward innovation and self-reliance through multiple acquisitions over the past years.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.